AAOS: Autologous chondrocyte implantation vs microfracture for articular cartilage lesions .
Two-year Follow Up of Randomized Controlled Trial of Arthroscopic Autologous Chondrocyte Implantation in the Knee
50 patients with articular cartilage lesions were randomized to treatment with either mircrofracture surgery or all-arthroscopic matrix encapsulated autologous chondrocyte implantation (MECI). The purpose was to compare the clinical and morphological outcomes between techniques following repair. Results up to 2 years postoperative revealed better T-2 mapping evaluations for repaired tissues and second-look arthroscopy scores in the MECI group. All clinical outcomes, however, were similar between groups.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
